AACR-Kids Beating Cancer Margaret Guedes Monosomy 7 Legacy Cancer Research Grant
This AACR grant funds research advancing understanding and treatment of monosomy 7 and high-risk AML to improve patient outcomes.
Funder: American Association for Cancer Research
Due Dates: December 1, 2026: Application Deadline
Funding Amounts: $300,000 total over 3 years (no indirect costs allowed)
Summary: Supports innovative research to advance understanding and treatment of monosomy 7 and high-risk AML subtypes, aiming to improve patient outcomes and survivorship.
Key Information: AACR Active Membership required by deadline; applicants must be independent investigators at an academic, medical, or research institution.
Description
This grant funds research that addresses critical unmet needs in acute myeloid leukemia (AML) with monosomy 7 and related high-risk cytogenetic subtypes. The program seeks projects in basic, translational, clinical, or population sciences that will drive new insights into disease biology, therapeutic vulnerabilities, response assessment, relapse, and survivorship. The ultimate goal is to accelerate progress toward better diagnostics, treatments, and outcomes for patients facing these aggressive forms of AML.
